Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/current-challenges-faced-by-cancer-clinical-trials-in-addressing-the-Qe2PpabefA
References (78)
-
Emma Aic, E. Nichols, C. Szoeke, S. Vollset, N. Abbasi, F. Abd-Allah, Jemal Abdela, Miloud Aichour, R. Akinyemi, Fares Alahdab, S. Asgedom, A. Awasthi, S. Barker-Collo, B. Baune, Y. Béjot, A. Belachew, D. Bennett, B. Biadgo, Ali Bijani, M. Sayeed, C. Brayne, D. Carpenter, F. Carvalho, F. Catalá-López, E. Cerin, J. Choi, Anh Dang, M. Degefa, Shirin Djalalinia, M. Dubey, Eyasu Duken, D. Edvardsson, M. Endres, S. Eskandarieh, Andre Faro, F. Farzadfar, S. Fereshtehnejad, E. Fernandes, I. Filip, F. Fischer, A. Gebre, D. Geremew, M. Ghasemi-Kasman, E. Gnedovskaya, Rajeev Gupta, V. Hachinski, T. Hagos, S. Hamidi, G. Hankey, J. Haro, S. Hay, S. Irvani, Ravi Jha, J. Jonas, Rizwan Kalani, A. Karch, A. Kasaeian, Y. Khader, I. Khalil, E. Khan, T. Khanna, T. Khoja, J. Khubchandani, A. Kisa, K. Kissimova-Skarbek, M. Kivimäki, A. Koyanagi, Kristopher Krohn, G. Logroscino, S. Lorkowski, M. Majdan, R. Malekzadeh, W. März, J. Massano, G. Mengistu, A. Meretoja, M. Mohammadi, M. Mohammadi‐Khanaposhtani, A. Mokdad, S. Mondello, G. Moradi, G. Nagel, M. Naghavi, G. Naik, L. Nguyen, T. Nguyen, Y. Nirayo, M. Nixon, R. Ofori-Asenso, F. Ogbo, A. Olagunju, M. Owolabi, S. Panda‐Jonas, V. Passos, David Pereira, G. Pinilla-Monsalve, M. Piradov, C. Pond, H. Poustchi, M. Qorbani, A. Radfar, R. Reiner, S. Robinson, G. Roshandel, A. Rostami, Tom Russ, P. Sachdev, H. Safari, S. Safiri, R. Sahathevan, Y. Salimi, Maheswar Satpathy, M. Sawhney, Mete Saylan, S. Sepanlou, Azadeh Shafieesabet, M. Shaikh, M. Sahraian, M. Shigematsu, R. Shiri, I. Shiue, J. Silva, Mari Smith, S. Sobhani, Dan Stein, R. Tabarés-Seisdedos, M. Tovani-Palone, B. Tran, T. Tran, Amanuel Tsegay, I. Ullah, N. Venketasubramanian, V. Vlassov, Yuan-Pang Wang, J. Weiss, R. Westerman, T. Wijeratne, G. Wyper, Y. Yano, Ebrahim Yimer, N. Yonemoto, M. Yousefifard, Z. Zaidi, Z. Zare, T. Vos, V. Feigin, C. Murray (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet. Neurology, 18
-
T. Cammen, P. Crome (2018)
Persistent exclusion of older people from clinical trials of cardiovascular and antithrombotic medicinal productsEuropean Geriatric Medicine, 9
-
Food and Drug Administration. Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry (draft guidance) -
E. Gray, J. Marti, J. Wyatt, D. Brewster, P. Hall (2019)
Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort studyPLoS Medicine, 16
-
(Hurria A. Cancer Network. Clinical Trials in Older Adults with Cancer: past and future. 2007. https://www.cancernetwork.com/view/clinical-trials-older-adults-cancer-past-and-future. Accessed 14 Oct 2020.)
Hurria A. Cancer Network. Clinical Trials in Older Adults with Cancer: past and future. 2007. https://www.cancernetwork.com/view/clinical-trials-older-adults-cancer-past-and-future. Accessed 14 Oct 2020.Hurria A. Cancer Network. Clinical Trials in Older Adults with Cancer: past and future. 2007. https://www.cancernetwork.com/view/clinical-trials-older-adults-cancer-past-and-future. Accessed 14 Oct 2020., Hurria A. Cancer Network. Clinical Trials in Older Adults with Cancer: past and future. 2007. https://www.cancernetwork.com/view/clinical-trials-older-adults-cancer-past-and-future. Accessed 14 Oct 2020.
-
T. Harris, I. Carey, C. Victor, R. Adams, D. Cook (2008)
Optimising recruitment into a study of physical activity in older people: a randomised controlled trial of different approaches.Age and ageing, 37 6
-
S. Mitchell, V. Mor, J. Harrison, E. McCarthy (2020)
Embedded Pragmatic Trials in Dementia Care: Realizing the Vision of the NIA IMPACT CollaboratoryJournal of the American Geriatrics Society, 68
-
E. Soto-Pérez-de-Celis, S. Lichtman (2017)
Considerations for clinical trial design in older adults with cancerExpert Opinion on Investigational Drugs, 26
-
M. Extermann, I. Boler, R. Reich, G. Lyman, Richard Brown, J. Defelice, R. Levine, E. Lubiner, P. Reyes, F. Schreiber, L. Balducci (2012)
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) scoreCancer, 118
-
A. Clegg, C. Relton, John Young, M. Witham (2015)
Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design.Age and ageing, 44 4
-
(Food and Drug Administration. Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry (draft guidance). 2020. https://www.fda.gov/media/135804/download. Accessed 18 Jan 2020.)
Food and Drug Administration. Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry (draft guidance). 2020. https://www.fda.gov/media/135804/download. Accessed 18 Jan 2020.Food and Drug Administration. Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry (draft guidance). 2020. https://www.fda.gov/media/135804/download. Accessed 18 Jan 2020., Food and Drug Administration. Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry (draft guidance). 2020. https://www.fda.gov/media/135804/download. Accessed 18 Jan 2020.
-
G. Doherty, Mehmet Goksu, B. Paula (2020)
Rethinking cancer clinical trials for COVID-19 and beyondNature Cancer, 1
-
C. Gross, Natalie Wong, J. Dubin, S. Mayne, H. Krumholz (2005)
Enrollment of older persons in cancer trials after the medicare reimbursement policy change.Archives of internal medicine, 165 13
-
Kimberly Willik, S. Schagen, M. Ikram (2018)
Cancer and dementia: Two sides of the same coin?European Journal of Clinical Investigation, 48
-
R. Chatters, Louise Newbould, K. Sprange, D. Hind, G. Mountain, Katy Shortland, L. Powell, Rebecca Gossage-Worrall, T. Chater, A. Keetharuth, Ellen Lee, B. Woods (2018)
Recruitment of older adults to three preventative lifestyle improvement studiesTrials, 19
-
C. Townsley, R. Selby, L. Siu (2005)
Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 13
-
A. Hurria, W. Dale, M. Mooney, J. Rowland, K. Ballman, H. Cohen, H. Muss, R. Schilsky, B. Ferrell, M. Extermann, K. Schmader, S. Mohile (2014)
Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 24
-
M. Kemeny, B. Peterson, A. Kornblith, H. Muss, Judith Wheeler, E. Levine, N. Bartlett, G. Fleming, H. Cohen (2003)
Barriers to clinical trial participation by older women with breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 12
-
(U.S. Department of Health and Human Services. Food and Drug Administration. Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies: Guidance for Industry. 2020. https://www.fda.gov/media/123745/download. Accessed 18 Jan 2020.)
U.S. Department of Health and Human Services. Food and Drug Administration. Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies: Guidance for Industry. 2020. https://www.fda.gov/media/123745/download. Accessed 18 Jan 2020.U.S. Department of Health and Human Services. Food and Drug Administration. Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies: Guidance for Industry. 2020. https://www.fda.gov/media/123745/download. Accessed 18 Jan 2020., U.S. Department of Health and Human Services. Food and Drug Administration. Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies: Guidance for Industry. 2020. https://www.fda.gov/media/123745/download. Accessed 18 Jan 2020.
-
L. Mody, Douglas Miller, J. McGloin, Marcie Freeman, E. Marcantonio, J. Magaziner, S. Studenski (2008)
Recruitment and Retention of Older Adults in Aging ResearchJournal of the American Geriatrics Society, 56
-
T. Estapé (2018)
Cancer in the Elderly: Challenges and BarriersAsia-Pacific Journal of Oncology Nursing, 5
-
Ruth Mary Parks, Y. Jauhari, J. Morgan, L. Wyld, K. Cheung (2020)
Special issues for older women with primary breast cancerBreast Cancer Management
-
Catalina Hernández-Torres, W. Cheung, S. Kong, C. O'Callaghan, T. Hsu (2020)
Accrual of older adults to cancer clinical trials led by the Canadian cancer trials group - Is trial design a barrier?Journal of geriatric oncology
-
B. Palmer, L. Dunn, P. Appelbaum, S. Mudaliar, L. Thal, R. Henry, S. Golshan, D. Jeste (2005)
Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.Archives of general psychiatry, 62 7
-
Cancer Research UK. A trial looking at anastrozole with or without surgery for older women with breast cancer (ESTEeM) -
Governor, Kody Kinsley, Secretary, Mark Payne (2020)
Health and Human ServicesCongress and the Nation 2013-2016, Volume XIV: Politics and Policy in the 113th and 114th Congresses
-
(Our World in Data. University of Oxfrod GCDL. 2020. https://ourworldindata.org. Accessed 24 Sep 2020.)
Our World in Data. University of Oxfrod GCDL. 2020. https://ourworldindata.org. Accessed 24 Sep 2020.Our World in Data. University of Oxfrod GCDL. 2020. https://ourworldindata.org. Accessed 24 Sep 2020., Our World in Data. University of Oxfrod GCDL. 2020. https://ourworldindata.org. Accessed 24 Sep 2020.
-
R. Freedman, T. Dockter, J. Lafky, A. Hurria, Hyman Muss, H. Cohen, A. Jatoi, M. Kemeny, K. Ruddy (2018)
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)The Oncologist, 23
-
(US Food and Drug Administration Guidance for Industry. Content and format for geriatric labeling. 2001. https://www.fda.gov/media/72141/download. Accessed 14 Oct 2020.)
US Food and Drug Administration Guidance for Industry. Content and format for geriatric labeling. 2001. https://www.fda.gov/media/72141/download. Accessed 14 Oct 2020.US Food and Drug Administration Guidance for Industry. Content and format for geriatric labeling. 2001. https://www.fda.gov/media/72141/download. Accessed 14 Oct 2020., US Food and Drug Administration Guidance for Industry. Content and format for geriatric labeling. 2001. https://www.fda.gov/media/72141/download. Accessed 14 Oct 2020.
-
Robert Leonard, Rachel Ballinger, David Cameron, Peter Ellis, Lesley Fallowfield, M. Gosney, L. Johnson, L. Kilburn, Andreas Makris, Janine Mansi, Malcolm Reed, A. Ring, Adam Robinson, Peter Simmonds, Gerry Thomas, Judith Bliss (2011)
Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?British Journal of Cancer, 105
-
Elizabeth Tolmie, M. Mungall, G. Louden, G. Lindsay, A. Gaw (2004)
Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants.Age and ageing, 33 4
-
(Mary Parks R, Jauhari Y, Morgan J, Wyld L, Cheung K-L. Special issues for older women with primary breast cancer. Breast Cancer Management. 2020;9(3):BMT43.)
Mary Parks R, Jauhari Y, Morgan J, Wyld L, Cheung K-L. Special issues for older women with primary breast cancer. Breast Cancer Management. 2020;9(3):BMT43.Mary Parks R, Jauhari Y, Morgan J, Wyld L, Cheung K-L. Special issues for older women with primary breast cancer. Breast Cancer Management. 2020;9(3):BMT43., Mary Parks R, Jauhari Y, Morgan J, Wyld L, Cheung K-L. Special issues for older women with primary breast cancer. Breast Cancer Management. 2020;9(3):BMT43.
-
Good Review Practice: Clinical Review of Investigational New Drug Applications -
(US Food and Drug Administration. Good Review Practice: Clinical Review of Investigational New Drug Applications. 2013. https://www.fda.gov/media/87621/download. Accessed 14 Oct 2020.)
US Food and Drug Administration. Good Review Practice: Clinical Review of Investigational New Drug Applications. 2013. https://www.fda.gov/media/87621/download. Accessed 14 Oct 2020.US Food and Drug Administration. Good Review Practice: Clinical Review of Investigational New Drug Applications. 2013. https://www.fda.gov/media/87621/download. Accessed 14 Oct 2020., US Food and Drug Administration. Good Review Practice: Clinical Review of Investigational New Drug Applications. 2013. https://www.fda.gov/media/87621/download. Accessed 14 Oct 2020.
-
(2020)
and Drug Administration -
(2020)
and Drug Administration Guidance for Industry -
M. Raji, Y. Kuo, J. Freeman, J. Goodwin (2008)
Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care.Archives of internal medicine, 168 18
-
(1999)
The National Academies Collection: Reports funded by National Institutes of HealthThe unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved
-
H. Allore, Mary Tinettia, T. Gill, P. Peduzzi (2005)
Experimental designs for multicomponent interventions among persons with multifactorial geriatric syndromesClinical Trials, 2
-
M. Reed, Lynda Wyld, Paul Ellis, Judith Bliss, Robert Leonard (2009)
Breast cancer in older women: trials and tribulations.Clinical oncology (Royal College of Radiologists (Great Britain)), 21 2
-
A. Bayer, W. Tadd (2000)
Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive studyBMJ : British Medical Journal, 321
-
H. Cohen, H. Muss (2006)
The Cancer and Leukemia Group B Cancer in the Elderly Committee: Addressing a Major Cancer NeedClinical Cancer Research, 12
-
University of Oxfrod GCDL -
Shóna Whelehan, O. Lynch, Niall Treacy, C. Gleeson, Andrea Oates, A. O'Donovan (2018)
Optimising Clinical Trial Design in Older Cancer PatientsGeriatrics, 3
-
D. Outlaw, G. Williams (2020)
Is the lack of evidence in older adults with cancer compromising safety?Expert Opinion on Drug Safety, 19
-
R. Yuval, K. Uziel, Nomi Gordon, A. Merdler, N. Khader, B. Karkabi, M. Flugelman, D. Halon, B. Lewis (2001)
Perceived benefit after participating in positive or negative / neutral heart failure trials: the patients' perspectiveEuropean Journal of Heart Failure, 3
-
Haynes Ma, B. Smedley (1999)
The unequal burden of cancer : an assessment of NIH research and programs for ethnic minorities and the medically underserved -
A. Hurria (2007)
Clinical trials in older adults with cancer: past and future.Oncology, 21 3
-
(Cancer Research UK. A trial looking at anastrozole with or without surgery for older women with breast cancer (ESTEeM). 2011. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-anastrozole-with-or-without-surgery-for-older-women-with-breast-cancer#undefined. Accessed 8 Oct 2020.)
Cancer Research UK. A trial looking at anastrozole with or without surgery for older women with breast cancer (ESTEeM). 2011. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-anastrozole-with-or-without-surgery-for-older-women-with-breast-cancer#undefined. Accessed 8 Oct 2020.Cancer Research UK. A trial looking at anastrozole with or without surgery for older women with breast cancer (ESTEeM). 2011. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-anastrozole-with-or-without-surgery-for-older-women-with-breast-cancer#undefined. Accessed 8 Oct 2020., Cancer Research UK. A trial looking at anastrozole with or without surgery for older women with breast cancer (ESTEeM). 2011. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-anastrozole-with-or-without-surgery-for-older-women-with-breast-cancer#undefined. Accessed 8 Oct 2020.
-
(Cancer Research UK. A trial comparing adjuvant chemotherapy with standard treatment for older women with early stage breast cancer (ACTION). 2010. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-adjuvant-chemotherapy-with-standard-treatment-for-older-women-with-early-stage-breast-cancer. Accessed 8 Oct 2020.)
Cancer Research UK. A trial comparing adjuvant chemotherapy with standard treatment for older women with early stage breast cancer (ACTION). 2010. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-adjuvant-chemotherapy-with-standard-treatment-for-older-women-with-early-stage-breast-cancer. Accessed 8 Oct 2020.Cancer Research UK. A trial comparing adjuvant chemotherapy with standard treatment for older women with early stage breast cancer (ACTION). 2010. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-adjuvant-chemotherapy-with-standard-treatment-for-older-women-with-early-stage-breast-cancer. Accessed 8 Oct 2020., Cancer Research UK. A trial comparing adjuvant chemotherapy with standard treatment for older women with early stage breast cancer (ACTION). 2010. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-adjuvant-chemotherapy-with-standard-treatment-for-older-women-with-early-stage-breast-cancer. Accessed 8 Oct 2020.
-
V. Fonseca, J. Caeiro (2020)
Bioethics and healthcare policies. The benefit of using genetic tests of BRCA 1 and BRCA 2 in elderly patients.The International journal of health planning and management
-
K. Saini, B. Heras, R. Plummer, V. Moreno, Marco Romano, J. Castro, P. Aftimos, J. Fredriksson, G. Bhattacharyya, M. Olivo, G. Schiavon, K. Punie, J. García-Foncillas, Ernesto Rogata, Richie Pfeiffer, C. Orbegoso, K. Morrison, G. Curigliano, Lynda Chin, M. Saini, Ø. Rekdal, Steven Anderson, J. Cortés, Manuela Leone, J. Dancey, C. Twelves, A. Awada (2020)
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to ArmsJCO Global Oncology, 6
-
Judith McHenry, Kathleen Insel, G. Einstein, Amy Vidrine, Kari Koerner, D. Morrow (2015)
Recruitment of Older Adults: Success May Be in the Details.The Gerontologist, 55 5
-
A. Hurria, Laura Levit, W. Dale, S. Mohile, H. Muss, L. Fehrenbacher, A. Magnuson, S. Lichtman, S. Bruinooge, E. Soto-Pérez-de-Celis, W. Tew, M. Postow, H. Cohen (2015)
Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 32
-
G. Kimmick, B. Peterson, A. Kornblith, J. Mandelblatt, Jeffrey Johnson, Judith Wheeler, R. Heinze, H. Cohen, H. Muss (2005)
Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 10
-
CTTI Recommendations: decentralized Clinical Trials -
J. Shabason, J. Mao, E. Frankel, N. Vapiwala (2015)
Patients willingness to participate in clinical trials for symptom alleviation during radiation therapy.Journal of Clinical Oncology, 33
-
L. Biganzoli, H. Wildiers, C. Oakman, L. Marotti, S. Loibl, I. Kunkler, M. Reed, S. Ciatto, A. Voogd, E. Brain, B. Cutuli, C. Terret, M. Gosney, M. Aapro, R. Audisio (2012)
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).The Lancet. Oncology, 13 4
-
V. Murthy, H. Krumholz, C. Gross (2004)
Participation in cancer clinical trials: race-, sex-, and age-based disparities.JAMA, 291 22
-
S. Moorcraft, C. Marriott, C. Peckitt, D. Cunningham, I. Chau, N. Starling, D. Watkins, S. Rao (2016)
Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient surveyTrials, 17
-
R. Lindley (2012)
Drug trials for older people.The journals of gerontology. Series A, Biological sciences and medical sciences, 67 2
-
C. Townsley, Kelvin Chan, G. Pond, C. Marquez, L. Siu, S. Straus (2006)
Understanding the attitudes of the elderly towards enrolment into cancer clinical trialsBMC Cancer, 6
-
(1999)
The Medically U. The National Academies Collection: Reports funded by National Institutes of Health -
(United Nations. Ageing. 2019. https://www.un.org/en/sections/issues-depth/ageing/. Accessed 21 Oct 2020.)
United Nations. Ageing. 2019. https://www.un.org/en/sections/issues-depth/ageing/. Accessed 21 Oct 2020.United Nations. Ageing. 2019. https://www.un.org/en/sections/issues-depth/ageing/. Accessed 21 Oct 2020., United Nations. Ageing. 2019. https://www.un.org/en/sections/issues-depth/ageing/. Accessed 21 Oct 2020.
-
Angelica Herrera, S. Snipes, Denae King, I. Torres‐Vigil, D. Goldberg, A. Weinberg (2010)
Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change.American journal of public health, 100 Suppl 1
-
H. Muss, S. Woolf, D. Berry, C. Cirrincione, R. Weiss, D. Budman, W. Wood, W. Wood, I. Henderson, C. Hudis, E. Winer, H. Cohen, Judith Wheeler, L. Norton (2005)
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.JAMA, 293 9
-
T. Fietz, M. Zahn, A. Köhler, E. Engel, M. Frank, L. Kruggel, M. Jänicke, N. Marschner (2017)
Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort studyBreast Cancer Research and Treatment, 167
-
Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies: Guidance for Industry -
J. Morgan, J. George, G. Holmes, Charlene Martin, M. Reed, S. Ward, S. Walters, K. Cheung, R. Audisio, L. Wyld (2020)
Breast cancer surgery in older women: outcomes of the Bridging Age Gap in Breast Cancer studyBritish Journal of Surgery, 107
-
H. Allore, K. Goldfeld, R. Gutman, Fan Li, J. Monin, M. Taljaard, T. Travison (2020)
Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with DementiaJournal of the American Geriatrics Society, 68
-
Joy Lewis, M. Kilgore, D. Goldman, E. Trimble, R. Kaplan, M. Montello, M. Housman, J. Escarce (2003)
Participation of patients 65 years of age or older in cancer clinical trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 7
-
Alistair Ring, Malcolm Reed, R. Leonard, Ian Kunkler, H. Muss, Hans Wildiers, Lesley Fallowfield, A. Jones, R. Coleman (2011)
The treatment of early breast cancer in women over the age of 70British Journal of Cancer, 105
-
(Clinical Trials Transformation Initiative (CTTI). CTTI Recommendations: decentralized Clinical Trials. 2018. https://www.ctti-clinicaltrials.org/projects/decentralized-clinical-trials. Accessed 18 Jan 2020.)
Clinical Trials Transformation Initiative (CTTI). CTTI Recommendations: decentralized Clinical Trials. 2018. https://www.ctti-clinicaltrials.org/projects/decentralized-clinical-trials. Accessed 18 Jan 2020.Clinical Trials Transformation Initiative (CTTI). CTTI Recommendations: decentralized Clinical Trials. 2018. https://www.ctti-clinicaltrials.org/projects/decentralized-clinical-trials. Accessed 18 Jan 2020., Clinical Trials Transformation Initiative (CTTI). CTTI Recommendations: decentralized Clinical Trials. 2018. https://www.ctti-clinicaltrials.org/projects/decentralized-clinical-trials. Accessed 18 Jan 2020.
-
Cancer Research UK. A trial comparing adjuvant chemotherapy with standard treatment for older women with early stage breast cancer (ACTION) -
A. Hurria, S. Mohile, A. Gajra, H. Klepin, H. Muss, A. Chapman, Tao Feng, David Smith, Can‐lan Sun, N. Glas, H. Cohen, V. Katheria, Caroline Doan, Laura Zavala, Abrahm Levi, C. Akiba, W. Tew (2016)
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 20
-
M. Mcmurdo, H. Roberts, S. Parker, Nikkiah Wyatt, Helen May, C. Goodman, S. Jackson, J. Gladman, S. O'mahony, K. Ali, E. Dickinson, P. Edison, Chris Dyer (2011)
Improving recruitment of older people to research through good practice.Age and ageing, 40 6
-
Payment and Reimbursement to Research Subjects -
(US Food and Drug Administration. Payment and Reimbursement to Research Subjects. 2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/payment-and-reimbursement-research-subjects. Accessed 14 Oct 2020.)
US Food and Drug Administration. Payment and Reimbursement to Research Subjects. 2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/payment-and-reimbursement-research-subjects. Accessed 14 Oct 2020.US Food and Drug Administration. Payment and Reimbursement to Research Subjects. 2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/payment-and-reimbursement-research-subjects. Accessed 14 Oct 2020., US Food and Drug Administration. Payment and Reimbursement to Research Subjects. 2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/payment-and-reimbursement-research-subjects. Accessed 14 Oct 2020.
- Publisher
- Springer Journals
- Copyright
- Copyright © The Author(s) 2021
- ISSN
- 2366-1070
- eISSN
- 2366-1089
- DOI
- 10.1007/s40487-021-00140-w
- Publisher site
- See Article on Publisher Site
Abstract
The number of older adults living with cancer is increasing. There is a clear lack of representation of older adults in clinical trials, including cancer trials. Reasons for this are multifactorial and complex and include protocol, patient and sponsor factors. Potential solutions to overcome issues with trial design include varied methods of recruitment with flexible inclusion criteria. Possible alternatives to randomised trials include prospective cohort studies, pragmatic trials and the use of national population-based data sets. Patient factors may be addressed by integration of geriatric assessment, so patients can be randomised or treated based on their individual needs. Additionally, standard protocols for including older adults with cognitive impairment should be developed, rather than automatic exclusion. Increased effort is needed from sponsors and governing health care bodies to make recruitment of older adults to clinical trials standard.
Journal
Oncology and Therapy – Springer Journals
Published: Jan 22, 2021